Potential applications of glycosaminoglycan-related compounds in Alzheimer's disease

Céline Morissette; Diane Lacombe; Xianqi Kong; Ahmed Aman; Pascale Krzywkowski; Lioudmila Rodionova; Mounia Azzi; Daniel Delorme; Barry D. Greenberg

doi:10.1007/978-0-387-71522-3_16

Potential applications of glycosaminoglycan-related compounds in Alzheimer's disease

Céline Morissette, Diane Lacombe, Xianqi Kong, Ahmed Aman, Pascale Krzywkowski, Lioudmila Rodionova, Mounia Azzi, Daniel Delorme, Barry D. Greenberg

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

Amyloid refers to extracellular proteinaceous fibrillar tissue deposits having a unique set of morphologic, tinctorial, ultrastructural, and protein-folding characteristics (Kisilevsky, 1996). Up to now, more than 25 amyloid proteins or peptides have been identified, each being associated with one type of amyloid deposit (for a review see: Westermark et al., 2005).

Original language	English (US)
Title of host publication	Pharmacological Mechanisms in Alzheimer's Therapeutics
Publisher	Springer New York
Pages	255-273
Number of pages	19
ISBN (Electronic)	9780387715223
ISBN (Print)	9780387715216
DOIs	https://doi.org/10.1007/978-0-387-71522-3_16
State	Published - 2007
Externally published	Yes

ASJC Scopus subject areas

General Pharmacology, Toxicology and Pharmaceutics
General Medicine

Access to Document

10.1007/978-0-387-71522-3_16

Cite this

@inbook{53d43f2d3f534d76acbb34d7a23e0db8,

title = "Potential applications of glycosaminoglycan-related compounds in Alzheimer's disease",

abstract = "Amyloid refers to extracellular proteinaceous fibrillar tissue deposits having a unique set of morphologic, tinctorial, ultrastructural, and protein-folding characteristics (Kisilevsky, 1996). Up to now, more than 25 amyloid proteins or peptides have been identified, each being associated with one type of amyloid deposit (for a review see: Westermark et al., 2005).",

author = "C{\'e}line Morissette and Diane Lacombe and Xianqi Kong and Ahmed Aman and Pascale Krzywkowski and Lioudmila Rodionova and Mounia Azzi and Daniel Delorme and Greenberg, {Barry D.}",

year = "2007",

doi = "10.1007/978-0-387-71522-3_16",

language = "English (US)",

isbn = "9780387715216",

pages = "255--273",

booktitle = "Pharmacological Mechanisms in Alzheimer's Therapeutics",

publisher = "Springer New York",

}

TY - CHAP

T1 - Potential applications of glycosaminoglycan-related compounds in Alzheimer's disease

AU - Morissette, Céline

AU - Lacombe, Diane

AU - Kong, Xianqi

AU - Aman, Ahmed

AU - Krzywkowski, Pascale

AU - Rodionova, Lioudmila

AU - Azzi, Mounia

AU - Delorme, Daniel

AU - Greenberg, Barry D.

PY - 2007

Y1 - 2007

N2 - Amyloid refers to extracellular proteinaceous fibrillar tissue deposits having a unique set of morphologic, tinctorial, ultrastructural, and protein-folding characteristics (Kisilevsky, 1996). Up to now, more than 25 amyloid proteins or peptides have been identified, each being associated with one type of amyloid deposit (for a review see: Westermark et al., 2005).

AB - Amyloid refers to extracellular proteinaceous fibrillar tissue deposits having a unique set of morphologic, tinctorial, ultrastructural, and protein-folding characteristics (Kisilevsky, 1996). Up to now, more than 25 amyloid proteins or peptides have been identified, each being associated with one type of amyloid deposit (for a review see: Westermark et al., 2005).

UR - http://www.scopus.com/inward/record.url?scp=84920130147&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84920130147&partnerID=8YFLogxK

U2 - 10.1007/978-0-387-71522-3_16

DO - 10.1007/978-0-387-71522-3_16

M3 - Chapter

AN - SCOPUS:84920130147

SN - 9780387715216

SP - 255

EP - 273

BT - Pharmacological Mechanisms in Alzheimer's Therapeutics

PB - Springer New York

ER -

Potential applications of glycosaminoglycan-related compounds in Alzheimer's disease

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this